Sachin M. Apte

2.4k total citations
60 papers, 1.2k citations indexed

About

Sachin M. Apte is a scholar working on Oncology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Sachin M. Apte has authored 60 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 16 papers in Molecular Biology and 16 papers in Reproductive Medicine. Recurrent topics in Sachin M. Apte's work include Ovarian cancer diagnosis and treatment (16 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Cancer-related molecular mechanisms research (6 papers). Sachin M. Apte is often cited by papers focused on Ovarian cancer diagnosis and treatment (16 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Cancer-related molecular mechanisms research (6 papers). Sachin M. Apte collaborates with scholars based in United States, Australia and India. Sachin M. Apte's co-authors include Robert M. Wenham, Johnathan M. Lancaster, Yin Xiong, Jerald J. Killion, Isaiah J. Fidler, Ardeshir Hakam, Siddharth G. Kamath, Dung‐Tsa Chen, Holly K. Dressman and Todd Boren and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Sachin M. Apte

58 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sachin M. Apte United States 20 540 335 327 230 128 60 1.2k
Paul Laissue Colombia 23 724 1.3× 413 1.2× 352 1.1× 364 1.6× 224 1.8× 69 2.1k
Charlotte S. Wilhelm-Benartzi United Kingdom 19 980 1.8× 318 0.9× 228 0.7× 150 0.7× 208 1.6× 41 1.6k
Stephen L. Rose United States 20 530 1.0× 192 0.6× 364 1.1× 228 1.0× 142 1.1× 33 1.1k
David J. Hunter United States 11 353 0.7× 227 0.7× 235 0.7× 313 1.4× 188 1.5× 14 1.4k
Satoshi Ohira Japan 18 838 1.6× 299 0.9× 375 1.1× 129 0.6× 250 2.0× 38 1.5k
Satoshi Takakura Japan 18 445 0.8× 141 0.4× 291 0.9× 245 1.1× 101 0.8× 37 1.1k
Sophia Apostolidou United Kingdom 18 1.0k 1.9× 320 1.0× 291 0.9× 117 0.5× 127 1.0× 42 1.5k
Valerie McGuire United States 20 430 0.8× 312 0.9× 352 1.1× 406 1.8× 130 1.0× 41 1.5k
Haruko Hiraike Japan 18 475 0.9× 132 0.4× 211 0.6× 193 0.8× 118 0.9× 54 1.2k
Gloria Ravegnini Italy 22 427 0.8× 269 0.8× 194 0.6× 164 0.7× 180 1.4× 87 1.4k

Countries citing papers authored by Sachin M. Apte

Since Specialization
Citations

This map shows the geographic impact of Sachin M. Apte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sachin M. Apte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sachin M. Apte more than expected).

Fields of papers citing papers by Sachin M. Apte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sachin M. Apte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sachin M. Apte. The network helps show where Sachin M. Apte may publish in the future.

Co-authorship network of co-authors of Sachin M. Apte

This figure shows the co-authorship network connecting the top 25 collaborators of Sachin M. Apte. A scholar is included among the top collaborators of Sachin M. Apte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sachin M. Apte. Sachin M. Apte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoogland, Aasha I., Brent J. Small, Laura B. Oswald, et al.. (2023). Relationships among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated with Chemotherapy for Gynecologic Cancer: A Controlled Comparison. Cancers. 15(13). 3407–3407. 5 indexed citations
2.
Oswald, Laura B., Danielle B. Tometich, Aasha I. Hoogland, et al.. (2022). Cumulative burden of symptomatology in patients with gynecologic malignancies undergoing chemotherapy.. Health Psychology. 41(11). 864–873. 5 indexed citations
3.
Marchion, Douglas C., Susan McCarthy, Ardeshir Hakam, et al.. (2021). Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes. PLoS ONE. 16(11). e0256615–e0256615. 3 indexed citations
4.
Hoffman, Mitchel S., Yin Xiong, Sachin M. Apte, William S. Roberts, & Robert M. Wenham. (2019). Twenty-year surgical trends in a gynecologic oncology fellowship training program: Implications for practice. Gynecologic Oncology. 155(2). 359–364. 10 indexed citations
5.
Rishi, Anupam, Kamran A. Ahmed, Dylan Hunt, et al.. (2019). High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: Outcome and toxicity. Gynecologic Oncology. 156(2). 349–356. 19 indexed citations
6.
Chon, Hye Sook, Sokbom Kang, Jae K. Lee, et al.. (2017). Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers. BMC Cancer. 17(1). 407–407. 11 indexed citations
7.
Bush, Stephen, Douglas C. Marchion, Yin Xiong, et al.. (2016). Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival. Molecular and Clinical Oncology. 4(3). 399–404. 7 indexed citations
8.
Dossett, Lesly A., Samir Dalia, Damon R. Reed, et al.. (2015). Clinical and pathologic predictors of survival in patients with endometrial stromal sarcoma.. 1(3). 253–261. 1 indexed citations
9.
Marchion, Douglas C., Elona Biçaku, Forough Abbasi, et al.. (2015). BAD-mediated apoptotic pathway is associated with human cancer development. International Journal of Molecular Medicine. 35(4). 1081–1087. 42 indexed citations
10.
Xiong, Yin, Douglas C. Marchion, Forough Abbasi, et al.. (2015). Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance. Gynecologic Oncology. 140(2). 259–263. 16 indexed citations
11.
Wenham, Robert M., James P. LaPolla, Hui‐Yi Lin, et al.. (2013). A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy. Gynecologic Oncology. 130(1). 19–24. 22 indexed citations
12.
Chen, Xin, Douglas C. Marchion, Yin Xiong, et al.. (2013). Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest. Gynecologic Oncology. 131(1). 207–212. 8 indexed citations
13.
Phillips, Kristin M., Leigh Anne Faul, Brent J. Small, et al.. (2012). Comparing the Retrospective Reports of Fatigue Using the Fatigue Symptom Index With Daily Diary Ratings in Women Receiving Chemotherapy for Gynecologic Cancer. Journal of Pain and Symptom Management. 46(2). 282–288. 7 indexed citations
14.
Biçaku, Elona, Yin Xiong, Hye Sook Chon, et al.. (2012). In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival. British Journal of Cancer. 106(12). 1967–1975. 32 indexed citations
15.
Chon, Hye Sook, Douglas C. Marchion, Yin Xiong, et al.. (2011). The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin. Gynecologic Oncology. 124(1). 119–124. 19 indexed citations
16.
Xiong, Yin, Siddharth G. Kamath, Todd Boren, et al.. (2010). Genomic-directed targeted therapy increases endometrial cancer cell sensitivity to doxorubicin. American Journal of Obstetrics and Gynecology. 203(2). 158.e1–158.e40. 4 indexed citations
17.
Bansal, Nisha, William S. Roberts, Sachin M. Apte, Johnathan M. Lancaster, & Robert M. Wenham. (2009). Electrothermal bipolar coagulation decreases the rate of red blood cell transfusions for pelvic exenterations. Journal of Surgical Oncology. 100(6). 511–514. 7 indexed citations
18.
Boren, Todd, Yin Xiong, Ardeshir Hakam, et al.. (2009). MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy. Gynecologic Oncology. 113(2). 249–255. 100 indexed citations
19.
Apte, Sachin M., Corazon D. Bucana, Jerald J. Killion, David M. Gershenson, & Isaiah J. Fidler. (2004). Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines. Gynecologic Oncology. 93(1). 78–86. 69 indexed citations
20.
Vaccarello, Luis, Sachin M. Apte, Philip T. Diaz, George Lewandowski, & Larry J. Copeland. (1997). Respiratory Failure from Metastatic Choriocarcinoma: A Survivor of Mechanical Ventilation. Gynecologic Oncology. 67(1). 111–114. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026